A detailed history of Brandywine Managers, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Brandywine Managers, LLC holds 697 shares of LLY stock, worth $554,581. This represents 0.67% of its overall portfolio holdings.

Number of Shares
697
Previous 588 18.54%
Holding current value
$554,581
Previous $532,000 15.98%
% of portfolio
0.67%
Previous 0.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $84,163 - $104,642
109 Added 18.54%
697 $617,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $426,223 - $534,515
588 New
588 $532,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brandywine Managers, LLC Portfolio

Follow Brandywine Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Managers, LLC with notifications on news.